Internal Medicine, Hematology & Oncology · Danville, PA
NPI
1932141835
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
100 N Academy Ave
Danville, PA, 17822
Phone (570) 271-6045
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
400 services
Medicare patients, 2024
115
Average age 69
Drug cost, 2024
$1.8M
770 prescriptions
Company payments, 2025
$13K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph P Lynch was code 99214 (office e&m - established), 278 times for 88 patients. In total Joseph P Lynch billed 400 services in 16 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 278 | 88 | $67.63 | $19K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 29 | 25 | $11.19 | $325 |
| 99215 Office E&M - Established | Facility | 15 | 14 | $108.28 | $1,624 |
| 99205 Office E&M - New | Facility | 13 | 13 | $117.78 | $1,531 |
By year: 2022 $31K for 423 services; 2023 $27K for 355 services; 2024 $27K for 400 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph P Lynch prescribed most often to Medicare patients was Acyclovir, with 103 prescriptions and refills. In total Joseph P Lynch wrote 770 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 103 | 127 | 31 | $2,011 |
| Brukinsa Zanubrutinib | 47 | 47 | Under 11 | $684K |
| Famotidine Generic | 28 | 36 | Under 11 | $203 |
| Cyclosporine Modified Cyclosporine, Modified | 26 | 32 | Under 11 | $3,444 |
| Eliquis Apixaban | 26 | 34 | Under 11 | $19K |
| Jakafi Ruxolitinib Phosphate | 21 | 21 | Under 11 | $356K |
| Shingrix Varicella-Zoster Ge/As01b/Pf | 19 | 19 | 14 | $3,533 |
| Acthib Haemoph B Poly Conj-Tet Tox/Pf | 18 | 18 | 13 | $233 |
| Potassium Chloride Generic | 17 | 19 | Under 11 | $430 |
| Ondansetron Hcl Generic | 17 | 25 | 11 | $310 |
| Prochlorperazine Maleate Generic | 17 | 17 | Under 11 | $335 |
| Fluconazole Generic | 17 | 21 | Under 11 | $843 |
| Prednisone Generic | 16 | 17 | Under 11 | $138 |
| Gabapentin Generic | 16 | 26 | Under 11 | $192 |
| Infanrix Dtap Diph,pertuss(Acell),tet Ped/Pf | 15 | 15 | Under 11 | $409 |
Brand drugs: 268 claims; generic drugs: 502 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph P Lynch $13K ($13K in general payments such as food, travel and fees) from 5 companies. The largest payer was Kite Pharma, Inc. with $9,770.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.